{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T23:37:47Z","timestamp":1770248267988,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"DOI":"10.1186\/s40644-025-00984-9","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T12:52:22Z","timestamp":1767790342000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of MRI-based models to predict lymph node metastasis in bladder cancer: a multi-center study"],"prefix":"10.1186","volume":"26","author":[{"given":"Rongjie","family":"Bai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingkai","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meihua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenghao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengye","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juntao","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qikai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenjiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaotong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"issue":"3","key":"984_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics, 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"19","key":"984_CR2","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis AT, Lec PM, Chamie K, Mshs MD. Bladder cancer: a review. JAMA. 2020;324(19):1980\u201391.","journal-title":"A Rev, JAMA"},{"issue":"7","key":"984_CR3","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1007\/s10147-025-02778-2","volume":"30","author":"T Sazuka","year":"2025","unstructured":"Sazuka T, Taoka R, Miki J, Saito R, Fukuokaya W, Matsui Y, et al. Impact of lymph-node dissection during radical cystectomy for non-muscle-invasive bladder cancer: Japanese multicenter retrospective study. Int J Clin Oncol. 2025;30(7):1417\u201325.","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"984_CR4","doi-asserted-by":"publisher","first-page":"18905","DOI":"10.1038\/s41598-025-03916-6","volume":"15","author":"S Huang","year":"2025","unstructured":"Huang S, Jia K, Cui J, Duan J, Li X, Chai W, et al. Impact of pelvic lymph node dissection on survival outcomes in non-muscle invasive bladder cancer: a multicenter retrospective study. Sci Rep. 2025;15(1):18905.","journal-title":"Sci Rep"},{"issue":"3","key":"984_CR5","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/JU.0000000000002266","volume":"207","author":"A Khanna","year":"2022","unstructured":"Khanna A, Miest T, Sharma V, Campbell R, Hensley P, Thapa P, et al. Role of lymphadenectomy during radical cystectomy for nonmuscle-invasive bladder cancer: results from a multi-institutional experience. J Urol. 2022;207(3):551\u201358.","journal-title":"J Urol"},{"issue":"3","key":"984_CR6","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.annonc.2021.11.012","volume":"33","author":"T Powles","year":"2022","unstructured":"Powles T, Bellmunt J, Comp\u00e9rat E, Santis MD, Huddart R, Loriot Y, et al. Bladder cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022;33(3):244\u201358.","journal-title":"Ann Oncol"},{"issue":"5","key":"984_CR7","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.eururo.2025.02.019","volume":"87","author":"AG van der Heijden","year":"2025","unstructured":"van der Heijden AG, Bruins HM, Carrion A, Cathomas R, Comp\u00e9rat E, Dimitropoulos K, et al. European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2025 guidelines. Eur Urol. 2025;87(5):582\u2013600.","journal-title":"Eur Urol"},{"key":"984_CR8","doi-asserted-by":"publisher","first-page":"1392062","DOI":"10.3389\/fonc.2024.1392062","volume":"14","author":"K Davis","year":"2024","unstructured":"Davis K, Orf J, Ballon-Landa E, Hamilton Z. Neoadjuvant chemotherapy prior to radical cystectomy for non-muscle invasive bladder cancer: national trends and pathologic outcomes. Front Oncol. 2024;14:1392062.","journal-title":"Front Oncol"},{"issue":"7","key":"984_CR9","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1038\/s41416-023-02383-y","volume":"129","author":"J Lu","year":"2023","unstructured":"Lu J, Lai J, Xiao K, Peng S, Zhang Y, Xia Q, et al. A clinically practical model for the preoperative prediction of lymph node metastasis in bladder cancer: a multicohort study. Br J Cancer. 2023;129(7):1166\u201375.","journal-title":"Br J Cancer"},{"issue":"1","key":"984_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13244-023-01569-5","volume":"15","author":"R Sun","year":"2024","unstructured":"Sun R, Zhang M, Yang L, Yang S, Li N, Huang Y, et al. Preoperative CT-based deep learning radiomics model to predict lymph node metastasis and patient prognosis in bladder cancer: a two-center study. Insights Imag. 2024;15(1):21.","journal-title":"Insights Imag"},{"key":"984_CR11","doi-asserted-by":"crossref","unstructured":"Sudjai N, Siriwanarangsun P, Lektrakul N, Saiviroonporn P, Maungsomboon S, Phimolsarnti R, et al. Robustness of radiomic features: two-dimensional versus three-dimensional MRI-based feature reproducibility in lipomatous soft-tissue tumors. Diagnostics (Basel). 2023;13(2).","DOI":"10.3390\/diagnostics13020258"},{"issue":"8","key":"984_CR12","doi-asserted-by":"publisher","first-page":"6116","DOI":"10.1007\/s00330-020-07572-4","volume":"31","author":"FHJ Elsholtz","year":"2021","unstructured":"Elsholtz FHJ, Asbach P, Haas M, Becker M, Beets-Tan RGH, Thoeny HC, Padhani AR, Hamm B. Introducing the node reporting and data system 1.0 (Node-RADS): a concept for standardized assessment of lymph nodes in cancer. Eur Radiol. 2021;31(8):6116\u201324.","journal-title":"Eur Radiol"},{"key":"984_CR13","doi-asserted-by":"crossref","unstructured":"Zhong J, Mao S, Chen H, Wang Y, Yin Q, Cen Q, et al. Node-RADS: a systematic review and meta-analysis of diagnostic performance, category-wise malignancy rates, and inter-observer reliability. Eur Radiol. 2024.","DOI":"10.1007\/s00330-024-11160-1"},{"key":"984_CR14","doi-asserted-by":"crossref","unstructured":"Leonardo C, Flammia RS, Lucciola S, Proietti F, Pecoraro M, Bucca B, et al. Performance of Node-RADS scoring system for a standardized assessment of regional lymph nodes in bladder cancer patients. Cancers (Basel). 2023;15(3).","DOI":"10.3390\/cancers15030580"},{"issue":"4","key":"984_CR15","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00345-018-2439-8","volume":"37","author":"J Crozier","year":"2019","unstructured":"Crozier J, Papa N, Perera M, Ngo B, Bolton D, Sengupta S, et al. Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis. World J Urol. 2019;37(4):667\u201390.","journal-title":"World J Urol"},{"key":"984_CR16","doi-asserted-by":"crossref","unstructured":"Gontero P, Birtle A, Capoun O, Comp\u00e9rat E, Dominguez\u2013Escrig JL, Liedberg F, et al. European association of urology guidelines on non\u00e9muscle\u00e9invasive bladder cancer (TaT1 and carcinoma in situ): a summary of the 2024 guidelines update. Eur Urol. 2024;86(6):531\u201349.","DOI":"10.1016\/j.eururo.2024.07.027"},{"issue":"3","key":"984_CR17","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.eururo.2018.04.029","volume":"74","author":"V Panebianco","year":"2018","unstructured":"Panebianco V, Narumi Y, Altun E, Bochner BH, Efstathiou JA, Hafeez S, et al. Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (Vesical Imaging-Reporting and Data System). Eur Urol. 2018;74(3):294\u2013306.","journal-title":"Eur Urol"},{"issue":"10","key":"984_CR18","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1002\/sim.1742","volume":"23","author":"LM Sullivan","year":"2004","unstructured":"Sullivan LM, Massaro JM, D\u2019Agostino RB Sr. Presentation of multivariate data for clinical use: the Framingham study risk score functions. Stat Med. 2004;23(10):1631\u201360.","journal-title":"Stat Med"},{"issue":"3","key":"984_CR19","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/sim.5941","volume":"33","author":"PC Austin","year":"2014","unstructured":"Austin PC, Steyerberg EW. Graphical assessment of internal and external calibration of logistic regression models by using loess smoothers. Stat Med. 2014;33(3):517\u201335.","journal-title":"Stat Med"},{"issue":"1","key":"984_CR20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159\u201374.","journal-title":"Biometrics"},{"issue":"4","key":"984_CR21","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1053\/j.semnuclmed.2021.12.004","volume":"52","author":"K Bouchelouche","year":"2022","unstructured":"Bouchelouche K. PET\/CT in bladder cancer: an update. Semin Nucl Med. 2022;52(4):475\u201385.","journal-title":"Semin Nucl Med"},{"key":"984_CR22","doi-asserted-by":"crossref","unstructured":"Bizzarri FP, Nelson AW, Colquhoun AJ, Lobo N. Utility of fluorodeoxyglucose positron emission tomography\/computed tomography in detecting lymph node involvement in comparison to conventional imaging in patients with bladder cancer with variant histology. Eur Urol Oncol. 2025.","DOI":"10.1016\/j.euo.2025.03.019"},{"issue":"6","key":"984_CR23","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41585-023-00842-y","volume":"21","author":"E Grobet-Jeandin","year":"2024","unstructured":"Grobet-Jeandin E, Lenfant L, Pinar U, Parra J, Mozer P, Renard-Penna R, et al. Management of patients with muscle-invasive bladder cancer with clinical evidence of pelvic lymph node metastases. Nat Rev Urol 2024;21(6):339\u201356.","journal-title":"Nat Rev Urol"},{"issue":"1","key":"984_CR24","doi-asserted-by":"publisher","first-page":"e232387","DOI":"10.1148\/radiol.232387","volume":"312","author":"Q Li","year":"2024","unstructured":"Li Q, Xu WY, Sun NN, Feng QX, Zhu ZN, Hou YJ, et al. MRI versus dual-energy CT in local-regional staging of gastric cancer. Radiology. 2024;312(1):e232387.","journal-title":"Radiology"},{"key":"984_CR25","doi-asserted-by":"crossref","unstructured":"Maksim R, Buczy\u0144ska A, Sidorkiewicz I, Kr\u0119towski AJ, Sierko E. Imaging and metabolic diagnostic methods in the stage assessment of rectal cancer. Cancers (Basel). 2024;16(14).","DOI":"10.3390\/cancers16142553"},{"key":"984_CR26","doi-asserted-by":"crossref","unstructured":"Zhou X, Lu Z, Zhang R, Zhang R, Huang G, Shi K, et al. The value of dual time point (18)F-FDG PET\/CT imaging in differentiating lymph node metastasis from reactive hyperplasia in bladder urothelial carcinoma. Acad Radiol. 2024.","DOI":"10.21203\/rs.3.rs-2442672\/v1"},{"issue":"1","key":"984_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1148\/radiol.14132921","volume":"273","author":"HC Thoeny","year":"2014","unstructured":"Thoeny HC, Froehlich JM, Triantafyllou M, Huesler J, Bains LJ, Vermathen P, et al. Metastases in normal-sized pelvic lymph nodes: detection with diffusion-weighted MR imaging. Radiology. 2014;273(1):125\u201335.","journal-title":"Radiology"},{"issue":"8","key":"984_CR28","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1016\/j.acra.2024.02.014","volume":"31","author":"X Zhou","year":"2024","unstructured":"Zhou X, Lu Z, Zhang R, Zhang R, Huang G, Shi K, et al. The value of dual time point (18)F-FDG PET\/CT imaging in differentiating lymph node metastasis from reactive hyperplasia in bladder urothelial carcinoma. Acad Radiol. 2024;31(8):3272\u201381.","journal-title":"Acad Radiol"},{"key":"984_CR29","doi-asserted-by":"publisher","first-page":"690324","DOI":"10.3389\/fonc.2021.690324","volume":"11","author":"Z Tian","year":"2021","unstructured":"Tian Z, Meng L, Wang X, Diao T, Hu M, Wang M, et al. Predictive nomogram and risk factors for lymph node metastasis in bladder cancer. Front Oncol. 2021;11:690324.","journal-title":"Front Oncol"},{"issue":"6","key":"984_CR30","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.eururo.2006.06.010","volume":"50","author":"PI Karakiewicz","year":"2006","unstructured":"Karakiewicz PI, Shariat SF, Palapattu GS, Perrotte P, Lotan Y, Rogers CG, et al. Precystectomy nomogram for prediction of advanced bladder cancer stage. Eur Urol. 2006;50(6):1254\u20131260; discussion 1261\u20131262.","journal-title":"Eur Urol"},{"issue":"2","key":"984_CR31","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1097\/JS9.0000000000002222","volume":"111","author":"J Wu","year":"2025","unstructured":"Wu J, Shang BQ, Shou JZ, Wang ZP. A nomogram for predicting lymph node metastases in nonmetastatic muscle-invasive bladder cancer: a SEER-based investigation. Int J Surg. 2025;111(2):2309\u201312.","journal-title":"Int J Surg"},{"issue":"1","key":"984_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/jmri.27361","volume":"55","author":"V Panebianco","year":"2022","unstructured":"Panebianco V, Pecoraro M, Giudice FD, Takeuchi M, Muglia VF, Messina E, Cipollari S, Giannarini G, Catalano C, Narumi Y. VI-RADS for bladder cancer: current applications and future developments. J Magn Reson Imag. 2022;55(1):23\u201336.","journal-title":"J Magn Reson Imag"},{"key":"984_CR33","doi-asserted-by":"crossref","unstructured":"Panebianco V, Briganti A, Efstathiou JA, Galgano SJ, Luk L, Muglia VF, et al. Multiparametric magnetic resonance imaging and vesical imaging-reporting and data system (VI-RADS) for bladder cancer diagnosis and staging: a guide for clinicians from the American College of Radiology VI-RADS steering committee. Eur Urol. 2025.","DOI":"10.1016\/j.eururo.2025.10.010"},{"key":"984_CR34","doi-asserted-by":"crossref","unstructured":"Zheng Q, Jian J, Wang J, Wang K, Fan J, Xu H, et al. Predicting lymph node metastasis status from primary muscle-invasive bladder cancer histology slides using deep learning: a retrospective multicenter study. Cancers (Basel). 2023;15(11).","DOI":"10.3390\/cancers15113000"},{"issue":"4","key":"984_CR35","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.euf.2020.01.007","volume":"6","author":"G Gakis","year":"2020","unstructured":"Gakis G. Management of muscle-invasive bladder cancer in the 2020s: challenges and perspectives. Eur Urol Focus. 2020;6(4):632\u201338.","journal-title":"Eur Urol Focus"},{"issue":"1","key":"984_CR36","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1245\/s10434-024-16422-2","volume":"32","author":"P Jiao","year":"2025","unstructured":"Jiao P, Wu S, Yang R, Ni X, Wu J, Wang K, et al. Deep learning predicts lymphovascular invasion status in muscle-invasive bladder cancer histopathology. Ann Surg Oncol. 2025;32(1):598\u2013608.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"984_CR37","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1016\/j.clgc.2014.09.007","volume":"13","author":"A Kanatani","year":"2015","unstructured":"Kanatani A, Nakagawa T, Kawai T, Naito A, Sato Y, Yoshida K, et al. Adjuvant chemotherapy is possibly beneficial for locally advanced or node-positive bladder cancer. Clin Genitourin Cancer. 2015;13(2):e107\u201312.","journal-title":"Clin Genitourin Cancer"},{"key":"984_CR38","doi-asserted-by":"crossref","unstructured":"Heck MM, Lehmann J, Amiel T, R\u00fcbben H, Albers P, Wolff JM, et al. Long-term results from the LEA randomized trial: extended versus standard lymph node dissection in patients with bladder cancer undergoing radical cystectomy. Eur Urol. 2025.","DOI":"10.1016\/j.eururo.2025.09.001"},{"key":"984_CR39","doi-asserted-by":"crossref","unstructured":"Cai L, Bai R, Cao Q, Sun W, Wang F, Liu X, et al. A non-invasive MRI-based multimodal fusion deep learning model (MF-DLM) for predicting overall survival in bladder cancer: a multicentre retrospective study. eClinicalMedicine. 2025;90:103640.","DOI":"10.1016\/j.eclinm.2025.103640"},{"issue":"5","key":"984_CR40","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/bju.16828","volume":"136","author":"M Ferro","year":"2025","unstructured":"Ferro M, Catellani M, Bianchi R, Fallara G, Tozzi M, Maggi M, et al. Enhanced prognostic value of four-tier hybrid grading system in Ta non-muscle-invasive bladder cancer. BJU Int 2025;136(5):882\u201390.","journal-title":"BJU Int"},{"issue":"8","key":"984_CR41","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1111\/j.1464-410X.2011.10482.x","volume":"109","author":"F Abdollah","year":"2012","unstructured":"Abdollah F, Sun M, Schmitges J, Djahangirian O, Tian Z, Jeldres C, et al. Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy. BJU Int. 2012;109(8):1147\u201354.","journal-title":"BJU Int"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-025-00984-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-025-00984-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-025-00984-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T10:37:35Z","timestamp":1770201455000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40644-025-00984-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["984"],"URL":"https:\/\/doi.org\/10.1186\/s40644-025-00984-9","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is a retrospective analysis and has received ethical approval from the Institutional Review Board (Approval Number: 2021-SR-409) of The First Affiliated Hospital of Nanjing Medical University. The study was conducted in strict accordance with the ethical principles outlined in the Declaration of Helsinki. Given the retrospective nature of the study, the requirement for informed consent was waived by the ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from patients for the use of their relevant information.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}